What are the pathophysiology and treatment options for subglottic stenosis?

Subglottic Stenosis: Pathophysiology and Treatment

Pathophysiology

Acquired subglottic stenosis develops primarily through iatrogenic mucosal injury from prolonged endotracheal intubation, leading to inflammation, ulceration, granulation tissue formation, and ultimately fibrotic scarring of the subglottic airway. 1

Key Pathophysiologic Mechanisms:

• Intubation-related injury: Prolonged intubation (≥7 days) and multiple reintubations (≥3 episodes) are the primary risk factors for acquired stenosis 1
• Tube size matters critically: A tube size-to-gestational age ratio >0.1 correlates with airway obstruction development 1
• Histologic progression: Mucosal trauma → squamous metaplasia and ulceration → submucosal fibrosis with chronic inflammation 1
• Granulation tissue formation: Circumferential nodular or polypoid granulations develop with thickened respiratory mucosa 1

Emerging Inflammatory Mechanisms:

• IL-23/IL-17A axis: This inflammatory pathway appears central to idiopathic subglottic stenosis (iSGS) pathogenesis 2
• PD-1/PD-L1 upregulation: Expression is increased in the inflammatory milieu, representing a potential immunotherapeutic target 2
• Mechanical trauma hypothesis: For iSGS, telescoping of the first tracheal ring within the cricoid cartilage may disrupt local blood supply, causing mucosal edema, ischemia, and fibrosis 3

Clinical Presentation:

• Fixed lesions produce biphasic stridor, while dynamic lesions cause inspiratory stridor only 1
• Postextubation stridor is a significant marker for moderate-to-severe stenosis 1
• In preterm infants, apnea may replace stridor due to easy fatigability 1

Treatment Approach

Algorithmic Treatment Strategy:

For severe subglottic stenosis, anterior cricoid split should be attempted first to widen the subglottic space and allow healing without tracheostomy; if this fails or the patient doesn't meet criteria, tracheostomy becomes necessary to bypass obstruction, followed by staged laryngotracheal reconstruction. 1

Treatment Algorithm by Severity and Characteristics:

Mild-to-Moderate Stenosis (Short, Recent, Grade I-II Mucosal)

• Endoscopic procedures are appropriate as primary treatment 4
• CO2 laser debridement + balloon dilation + intralesional steroid injection performed at 3-month intervals 5
• Racemic epinephrine provides temporary relief during acute exacerbations with upper respiratory infections by reducing superimposed edema 1
• Systemic corticosteroids have been used early in the course, though effectiveness lacks formal assessment 1

Severe Isolated Subglottic Stenosis

• Anterior cricoid split with cartilage graft is the preferred external approach 4
• If anterior cricoid split fails, proceed to tracheostomy 1

Subglottic + Glottic or High Subglottic Involvement

• Anterior + posterior cricoid split with cartilage graft 4

Subglottic + Tracheal Involvement

• Cricotracheal resection with anastomosis 4
• Single-stage tracheal resection and anastomosis represents the gold standard when feasible 6

Complex or Refractory Cases

• Laryngotracheal reconstruction through tracheostomy allows gradual surgical correction 1
• Balloon dilation under direct visualization or fluoroscopic guidance for distal stenoses 1
• Electroresection for specific lesions 1
• Open tube resection of granulation tissue for fixed airway obstruction 1

Special Considerations for GPA-Associated Stenosis:

For actively inflamed subglottic/endobronchial tissue with stenosis in granulomatosis with polyangiitis (GPA), immunosuppressive therapy should be used over surgical dilation with intralesional glucocorticoid injection alone. 1

• Immunosuppressive therapy (glucocorticoids plus other agents) is recommended for initial treatment of active inflammatory stenoses 1
• Surgical dilation with intralesional glucocorticoid injection is more appropriate for longstanding, fibrotic, or immunosuppression-unresponsive stenoses 1
• Concurrent surgical dilation with medical treatment may be considered for stenoses requiring immediate intervention (e.g., critical narrowing) 1
• Endoscopic approaches require multiple procedures to achieve remission; open transcervical approach shows excellent results after endoscopic failure 7

Stenting Considerations:

Stent placement should be reserved for cases where other therapeutic bronchoscopic and systemic treatments have failed, as stents carry significant complications including mucus plugging, granulation tissue formation, migration, fracture, and infections. 1

• For patients unfit for surgery, custom-made transcordal stents offer a valid alternative to tracheostomy, preserving airway patency, swallowing, and phonation 6
• Stent use should be avoided if airway debridement alone can achieve patency 1

Predictors of Treatment Success:

• Negative predictors for decannulation: Higher BMI and older age significantly reduce decannulation success 5
• Granulation tissue presence: Associated with higher number (4+) of dilation procedures and need for open procedures 8
• Tracheomalacia and pulmonary disease history: Both associated with need for open procedures 8
• External injury stenosis has worse profile than intubation injury stenosis, with frequent vocal fold immobility and cartilage framework involvement 4

Prevention Strategies:

• Minimize intubation duration or avoid intubation altogether using nasal CPAP when possible 1
• Appropriate endotracheal tube sizing is critical (tube size-to-gestational age ratio ≤0.1) 1
• Shallow suctioning technique rather than deep suctioning reduces mucosal injury 1
• Nasal intubation may reduce reintubation frequency compared to oral intubation 1

Critical Pitfalls:

• Endoscopic procedures have limited indications as primary procedures for severe stenosis but serve as useful adjunctive procedures 4
• Tracheostomy delays speech development and increases specialized care needs, so it should only be undertaken when other obstruction-correction means are exhausted 1
• Idiopathic SGS causes submucosal fibrosis that regenerates spontaneously, so treatment provides effective palliation but not cure, unlike traumatic stenosis 9
• Prophylactic antibiotics do not prevent or decrease stenosis incidence despite infection being proposed as a risk factor 1